iGeneTech Secures RMB 50 Million Series B Funding Led by Jinke Junchuang Capital

On August 28, iGeneTech Biotechnology Co., Ltd., Beijing, China announced the completion of its RMB 50 million Series B financing round. The round was led by Jinke Junchuang Capital, a firm focused on investing in technology-driven enterprises powered by technological innovation, with continued participation from existing investors such as Legend Star.

It is understood that the funds from this round will be primarily used to accelerate the commercialization of its technology platform, speed up sales and marketing deployment in the Chinese market, and deepen business expansion.

iGeneTech, established in 2014, is a high-tech enterprise located in the Zhongguancun Life Science Park in Beijing. Specializing in the research, development, and innovation of targeted capture technologies for high-throughput sequencing, as well as the design and manufacturing of genetic testing products, iGeneTech operates as a production and service platform driven by genetic testing technologies. Leveraging its two proprietary core technologies—liquid-phase probe capture (TargetSeq®) and multiplex PCR amplification capture (MultipSeq®)—iGeneTech has developed a diversified product portfolio that includes gene capture reagents and kits, capture sequencing solutions, and synthetic biology offerings. The company is committed to advancing the translation and application of targeted capture technologies across various fields, including precision medicine, scientific research, general health, agriculture, public health, and forensics.

To date, iGeneTech has provided high-quality, efficient, and cost-effective customized kit manufacturing and genetic testing solutions to hundreds of sequencing companies and thousands of physicians and researchers.

Prior to this, iGeneTech had also garnered interest from investors such as Puhua Capital and Zhongguancun Development Group, raising over RMB 100 million in total. As one of the few “Made in China” brands in the upstream NGS sector, it has earned a strong reputation within the industry.